A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation

Transplantation

Volumn 93, Issue 8, 2012, Pages 822-826

  Mudge, David W ^a   Tan, Ken Soon ^a,b   Miles, Rhianna ^c   Johnson, David W ^a   Badve, Sunil V ^a   Campbell, Scott B ^a   Isbel, Nicole M ^a   Van Eps, Carolyn L ^a   Hawley, Carmel M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Logan Hospital   (Australia)

^c GREENSLOPES PRIVATE HOSPITAL   (Australia)

Author keywords

Anemia; Iron; Kidney transplantation

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; IRON POLYMALTOSE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISOLONE; TACROLIMUS; TRANSFERRIN;

ABDOMINAL CRAMP; ACUTE GRAFT REJECTION; ADULT; ANEMIA; ARTHRALGIA; ARTICLE; BLOOD TRANSFUSION; BRONCHOSPASM; CHILL; CHRONIC GLOMERULONEPHRITIS; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUSHING; GRAFT INFECTION; HAZARD RATIO; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA AND VOMITING; OPEN STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; SWEATING; THORAX PAIN; TREATMENT OUTCOME;

ADULT; ANEMIA; BLOOD TRANSFUSION; FEMALE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; GRAFT REJECTION; HUMANS; INFECTION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYSACCHARIDES; TREATMENT OUTCOME;

EID: 84859627341     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318248375a     Document Type: Article

References (13)

1. Saito S, Fujiwara T, Sakagami K, et al. Anemia following renal transplantation. Transplant Proc 1998; 30: 3025.
2. Mix TC, Kazmi W, Khan S, et al. Anemia: A continuing problem following kidney transplantation. Am J Transplant 2003; 3: 1426.
3. Yorgin PD, Belson A, Sanchez J, et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 2002; 40: 1306.
4. Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 2003; 3: 835.
5. Molnar MZ, Czira M, Ambrus C, et al. Anemia is associated with mortality in kidney-transplanted patients - A prospective cohort study. Am J Transplant 2007; 7: 818.
6. Turkowski-Duhem A, Kamar N, Cointault O, et al. Predictive factors of postrenal transplant anemia. Transplant Proc 2005; 37: 1009.
7. Miles AM, Markell MS, Daskalakis P, et al. Anemia following renal transplantation: Erythropoietin response and iron deficiency. Clin Transplant 1997; 11: 313.
8. Morii M, Ueno K, Ogawa A, et al. Impairment of mycophenolate mofetil absorption by iron ion. Clin Pharmacol Ther 2000; 68: 613.
9. Mudge DW, Atcheson B, Taylor PJ, et al. The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: A randomized, controlled trial. Transplantation 2004; 77: 206.
10. Gillespie RS, Symons JM. Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients. Pediatr Transplant 2005; 9: 43.
11. Zheng S, Coyne DW, Joist H, et al. Iron deficiency anemia and iron losses after renal transplantation. Transpl Int 2009; 22: 434.
12. ANZDATA Registry 2009 Report. 2011. Available at: http://www. anzdata.org.au/anzdata/AnzdataReport/33rdReport/Ch08.pdf. Accessed January 15, 2012.
13. Mudge DW, Tan KS, Miles R, et al. Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients. BMC Nephrol 2009; 10: 14.